Alpern Robert J bought ABBV
March 31, 2026 · Form 4 insider transaction
Alpern Robert J bought 35 shares of AbbVie Inc. at $217.49 per share, a transaction worth $7.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.; Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.